Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary

Affiliations

• ¹ Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
• ² 1st Department of Medicine, Division of Haematology, Clinical Center, Medical School, University of Pecs, Pecs, Hungary.
• ³ RxTarget Ltd., Szolnok, Hungary.
• ⁴ Department of Biostatistics, University of Veterinary Medicine, Budapest, Hungary.
• ⁵ Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.